W Robert Lee

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Cancer

Prostate cancer and prostatic diseases

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Duke University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke University Aug 01 2006

United States

Professor :: Radiation Oncology

Publications

W Robert Lee, James J Dignam, Mahul B Amin, Deborah Watkins Bruner, Daniel Low, Gregory P Swanson, Amit B Shah, David D'Souza, Jeff M Michalski, Ian S Dayes, Samantha Andrews Seaward, William A Hall, Paul L Nguyen, Thomas M Pisansky, Sergio L Faria, Yuhchyau Chen, Joseph P Rodgers, Howard M Sandler
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
W Robert Lee, James J Dignam, Mahul B Amin, Deborah Watkins Bruner, Daniel Low, Gregory P Swanson, Amit B Shah, David D'Souza, Jeff M Michalski, Ian S Dayes, Samantha Andrews Seaward, William A Hall, Paul L Nguyen, Thomas M Pisansky, Sergio L Faria, Yuhchyau Chen, Joseph P Rodgers, Howard M Sandler
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
W Robert Lee, James J Dignam, Mahul B Amin, Deborah Watkins Bruner, Daniel Low, Gregory P Swanson, Amit B Shah, David D'Souza, Jeff M Michalski, Ian S Dayes, Samantha Andrews Seaward, William A Hall, Paul L Nguyen, Thomas M Pisansky, Sergio L Faria, Yuhchyau Chen, Joseph P Rodgers, Howard M Sandler
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman, Susan Halabi, Lauren E Howard, Monika Anand, Daniel J George, Tian Zhang, William R Berry, W Robert Lee, Michael R Harrison, Paul G Corn, Andrew J Armstrong
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer. Prostate cancer and prostatic diseases (2024)
David J Carpenter, Joseph K Salama, W Robert Lee, Matthew J Boyer
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415. Prostate cancer and prostatic diseases (2023)
Edina C Wang, W Robert Lee, Andrew J Armstrong
Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer. Prostate cancer and prostatic diseases (2022)
Ryan Fecteau, W Robert Lee
The importance of body composition in patients with prostate cancer receiving radiotherapy. Cancer 129 (5) (2022)
Ryan Fecteau, W Robert Lee
The importance of body composition in patients with prostate cancer receiving radiotherapy. Cancer 129 (5) (2022)
Ryan Fecteau, W Robert Lee
The importance of body composition in patients with prostate cancer receiving radiotherapy. Cancer (2022)
Curtiland Deville, W Robert Lee
Reconciling outcomes for Black men with prostate cancer within and outside the Veterans Health Administration. Cancer 127 (3) (2020)
W Robert Lee
Proton-beam therapy after radical prostatectomy: Continued DVH idolatry? Cancer 125 (23) (2019)

W Robert Lee.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

W Robert Lee